Association between NS3 and NS5 Proteins of Dengue Virus Type 2 in the by Kapoor, Mini et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Virology Papers Virology, Nebraska Center for 
8-11-1995 
Association between NS3 and NS5 Proteins of Dengue Virus Type 
2 in the 
Mini Kapoor 
Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine 
Luwen Zhang 
Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, 
lzhang2@unl.edu 
Muralidhara Ramachandra 
Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD 
Jingo Kusukawa 
Dept. of Oral and Maxillofacial Surgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 
Fukuoka 830-91, Japan 
Kurt E. Ebner 
University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/virologypub 
 Part of the Virology Commons 
Kapoor, Mini; Zhang, Luwen; Ramachandra, Muralidhara; Kusukawa, Jingo; Ebner, Kurt E.; and 
Padmanabhan, R., "Association between NS3 and NS5 Proteins of Dengue Virus Type 2 in the" (1995). 
Virology Papers. 149. 
https://digitalcommons.unl.edu/virologypub/149 
This Article is brought to you for free and open access by the Virology, Nebraska Center for at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Virology Papers by an 
authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
Mini Kapoor, Luwen Zhang, Muralidhara Ramachandra, Jingo Kusukawa, Kurt E. Ebner, and R. 
Padmanabhan 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
virologypub/149 
Abstract
Dengue virus type 2, a member of the family Flaviviridae, encodes a sin-
gle polyprotein precursor consisting of 3391 amino acid residues that is 
processed to at least 10 mature proteins by host and viral proteases. The 
NS3 protein contains a domain commonly found in cellular serine pro-
teinases that in cooperation with NS2B is involved in polyprotein pro-
cessing. In addition, NS3 and NS5 proteins contain conserved motifs 
found in several RNA helicases and RNA-dependent RNA polymerases, 
respectively. Both enzymatic activities have been suggested to be in-
volved in viral RNA replication. In this report, we demonstrate that the 
NS3 and NS5 proteins interact in vivo in dengue virus type 2-infected 
monkey kidney (CV-1) cells and in HeLa cells coinfected with recom-
binant vaccinia viruses encoding these proteins as shown by coimmuno-
precipitations and immunoblotting methods. We also show by immuno-
fluorescence, metabolic labeling, and two-dimensional peptide mapping 
that NS5 is a nuclear phosphoprotein and that phosphorylation occurs on 
serine residues at multiple sites. Furthermore, NS5 exists in differentially 
phosphorylated states in the nuclear and the cytoplasmic fractions, and 
only the cytoplasmic form of NS5 is found to coimmunoprecipitate with 
NS3, suggesting that differential phosphorylation may control the inter-
action between these proteins and its function in the viral RNA replicase.
Abbreviations: DEN-2, dengue virus type 2; NS, nonstructural protein 
denoting the virus-specific proteins expressed only in the infected cells 
as opposed to being a component of the virion; PBS, phosphate-buffered 
saline; vv, vaccinia virus; PAGE, polyacrylamide gel electrophoresis; Ni 
NTA, nickel-nitrilotriacetic acid.
Introduction 
Dengue virus type 2 (DEN-2), a member of the family of Flavi-
viridae, has a single-stranded RNA genome of positive-strand polar-
ity containing 10,723 nucleotides (in New Guinea C strain; Reference 
1). The 5′ end of the genomic RNA has a type I cap, and the 3′ end is 
devoid of a poly(A) tail (for reviews, see 2, 3, 4, 5, 6). The genomic 
RNA has a single open reading frame containing 10,173 nucleotides 
encoding a polyprotein of 3391 amino acid residues with a gene order 
of 5′-C-prM-E-NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5-3′, which 
is processed into three structural proteins that are components of the 
virion (C, prM, and E) and at least seven nonstructural proteins, NS1 
to NS5, which are expressed in the infected cells (6).
The processing of the structural region of the polyprotein is car-
ried out by the host signal peptidase associated with the endoplasmic 
reticulum (7, 8, 9, 10). The processing of the nonstructural protein 
precursors at 2A-2B, 2B-3, 3-4A, and 4B-5 sites containing two ba-
sic amino acid residues (such as RR, RK, and KR) followed by a G, 
A, or S is well characterized, and it requires both NS2B and the N-
terminal 180 amino acid residues of NS3 containing the conserved 
catalytic triad of the serine proteinase family (11, 12, 13, 14, 15, 16, 
17, 18, 19, 20). However, functions of the viral nonstructural pro-
teins in genome replication are not well defined.
The region immediately C-terminal to the catalytic triad of the 
serine protease domain of NS3 contains conserved segments of NTP-
binding proteins and DEAD family of RNA helicases (12, 21, 22), 
and in this regard, NS3 appears to be a bifunctional protein. The 
RNA helicase function of NS3 has not yet been demonstrated, but 
it has been implicated in an unwinding step of genomic RNA rep-
lication, which is thought to occur through the formation of a dou-
ble-stranded RNA replicative intermediate (23, 24, 25, and 42; for 
a review, see reference 5). NS5, the largest protein of the virus, is 
the putative RNA-dependent RNA polymerase involved in viral 
RNA replication based on the conserved motif GDD found in sev-
eral RNA-dependent RNA polymerases (26, 27, 28 ; for a review, see 
references 6 and 21) and is thought to be involved in the formation 
of this replicative intermediate form. Thus, NS3 and NS5 are thought 
to be the components of the putative viral RNA replicase complex. 
We have overproduced NS3 and NS5 proteins using the recombinant 
vaccinia virus expression system (29, 30) with a focus on the charac-
terization of these two proteins for their enzymatic activities and for 
their role in viral RNA replication.
In this report, we demonstrate that NS3 and NS5 proteins inter-
act in vivo in cells infected with either DEN-2 or with recombinant 
vaccinia viruses encoding these proteins. The NS3 protein also binds 
in vitro to a C-terminally modified form of NS5 protein immobi-
lized to an affinity matrix. Localization by immunofluorescence us-
ing NS3- or NS5-specific antibodies shows that NS3 is localized in 
the cytoplasm and perinuclear region, whereas NS5 is localized pre-
dominantly in the nucleus of DEN-2 infected cells, although diffuse 
cytoplasmic localization of NS5 is also observed. Immunoprecipita-
tion analysis of the cytoplasmic and nuclear extracts from these cells 
shows two forms of NS5 in the cytoplasm separable by their electro-
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phoretic mobilities, and only one of these forms is predominantly lo-
cated in the nucleus. NS3 coimmunoprecipitated with only one form 
of NS5 in the cytoplasmic extract. Furthermore, we show that NS5 is 
phosphorylated in vivo at serine residues at multiple sites. The elec-
trophoretic mobilities of the two forms of NS5 are altered upon treat-
ment with a phosphatase, indicating that NS5 exists in differentially 
phosphorylated states.
Experimental Procedures
Materials and Cell Lines — [32P]Orthophosphate (carrier-free, 285 Ci/mg 
phosphate) and trans 35S-label (1000 Ci/mmol) were obtained from ICN Ra-
diochemicals. The cellulose-coated thin-layer plates were purchased from EM 
Sciences (Cherry Hill, NJ). The phosphoamino acid standards, iodoacetamide, 
phenylmethylsulfonyl fluoride, potato acid phosphatase, tosylphenylalanyl 
chloromethyl ketone-treated trypsin, bovine serum albumin, and the methi-
onine-free Dulbecco’s modified Eagle’s medium were purchased from Sigma.
Monkey kidney (CV-1), BSC-1 cells, and human TK– (143B) cells were 
grown in Dulbecco’s modified Eagle’s medium supplemented with fetal bo-
vine serum (10%). HeLa cells were grown in suspension culture in Dulbec-
co’s modified Eagle’s medium supplemented with 7% mixed serum (3.5% 
new born bovine serum and 3.5% bovine serum). To prepare a monolayer of 
HeLa cells, HeLa cells growing in a suspension culture were pelleted, washed 
with Dulbecco’s modified Eagle’s medium containing fetal bovine serum 
(10%), and then plated in a suitable flask. DEN-2 virus (New Guinea strain C) 
was originally obtained from Walter Reed Army Institute of Research (Wash-
ington, D. C.) and was propagated in CV-1 cells. A laboratory strain of vac-
cinia virus, WR strain, as well as the recombinant vaccinia virus encoding 
the T7 RNA polymerase, vTF7-3, were originally obtained from Dr. Bernard 
Moss and then propagated in HeLa cells (31).
Construction of Recombinant Vaccinia Viruses Encoding NS3, NS5, and 
NS5 with a C-terminal Histidine Tag — To construct recombinant vaccinia 
viruses encoding NS3 and NS5, CV-1 cells were infected with the wild-type 
(WR strain) vaccinia virus, followed by transfection with the expression 
plasmids encoding full-length NS3 and NS5 cloned into the T7 hybrid ex-
pression vector pTM1 (30). To construct NS5 with a C-terminal histine tag, 
we used a modified pTM-1 vector (pJK3) (J. Kusukawa and R. Padmanab-
han, unpublished results) containing a region encoding the synthetic FLAG 
(DYKDDDDK) epitope (32), for which a commercial monoclonal antibody 
is available (Kodak Scientific Imaging Systems, New Haven, CT), and six 
histidine residues (33). pJK3 was digested with ClaI and XhoI and a 4.7-ki-
lobase pair fragment was purified. pLZNS5 (19) was digested with ClaI and 
EagI and a 3-kilobase pair fragment was purified. A third fragment was ob-
tained by polymerase chain reaction using pLZNS5 as template and the prim-
ers, 5′-GAAAGACGGCCGCGTACT and 5′-TAGTCCTCGAGCCACAG-
GACTCCTGCCTC. The three fragments were ligated to yield the pNS5.H6. 
To construct the recombinant virus, this expression plasmid was transfected 
into CV-1 cells as described above. Cell lysates were prepared by subjecting 
the transfected cells to five freeze-thaw cycles. The recombinant viruses en-
coding the NS3, NS5, and NS5.H6 (vvNS3, vvNS5, and vvNS5.H6) having 
the TK– phenotype were selected by infecting a human TK– cell line (HuTK–
143B) in the presence of the 5-bromodeoxyuridine and screened by Southern 
hybridization. The recombinant virus stocks were prepared as described (31). 
For immunoprecipitations and immunoblot analysis, rabbit polyclonal anti-
body against NS5 and NS3 were used (19, 34).
Indirect Immunofluorescence — For subcellular localization of NS3 and 
NS5 by immunofluorescence, CV-1 cells were infected with DEN-2 virus at 
50 plaque forming units/cell. At 48 h postinfection, the cells were detached 
from the monolayers by trypsin treatment and plated onto glass coverslips. 
The infected cells were washed briefly with cold phosphate-buffered saline 
(PBS), pH 7.2, fixed in cold acetone (kept at –20 °C) for 20 min, and air-dried 
for 15 min (35). Cells were briefly rehydrated in cold PBS and incubated with 
200 µl of rabbit polyclonal antibody (1:30) in PBS at 37 °C for 1 h. Subse-
quently, they were subjected to three 10-min washes with cold PBS and in-
cubated with 200 µl of fluorescein isothiocyanate-conjugated goat anti-rabbit 
IgG (1:30) in PBS at 37 °C for 1 h. Cells were finally washed 3 times (10 min 
each) with cold PBS, coated with 90% glycerol in PBS, and observed under a 
microscope (Nikon Diaphot) with an epifluorescence attachment.
Metabolic Labeling with 32P and 35S — Monolayers of HeLa cells were 
coinfected with vTF7-3 and vvNS3 or vvNS5 at 5 plaque forming units/cell 
for each virus. In experiments in which both NS3 and NS5 were expressed, 
the vTF7-3, vvNS3, and vvNS5 were used at 5, 2.5, and 2.5 plaque forming 
units/cell, respectively. For in vivo labeling, HeLa cells infected with vvNS3 
and vvNS5 at 13 h postinfection (or CV-1 cells infected with DEN-2 at 36 
h postinfection) were washed and incubated for 1 h in methionine-free me-
dium supplemented with 5% dialyzed fetal bovine serum. The medium was 
replaced with the one containing [35S]methionine (at a final concentration of 
100 µCi/ml) and incubated for 4 h at 37 °C. For 32P labeling, cells were in-
cubated for 1 h with phosphate-free Joklik’s modified Eagle’s medium sup-
plemented with 5% dialyzed fetal bovine serum and 20 mM HEPES, pH 7.5, 
and then in a medium containing [32P]orthophosphate (carrier-free, 285 Ci/
mg phosphate, and 1 mCi/flask) for 4 h.
Cell Lysis and Immunoprecipitation — Cells were lysed in 1 ml of a buf-
fer containing 50 mM Tris-HCl, pH 7.4, 0.25 M NaCl, 0.1% Triton X-100, 5 
mM EDTA, 1 mM iodoacetamide, and 1 mM phenylmethylsulfonyl fluoride. 
The cell lysates were treated with micrococcal nuclease for 45 min at 37 °C 
to digest nucleic acids, precleared with normal rabbit serum, and then immu-
noprecipitated as described before (36). For the analysis of labeled phospho-
proteins, the immunoprecipitation buffer was supplemented with 0.2% SDS. 
The immunoprecipitated protein was dissociated from protein A-agarose by 
boiling for 5 min in the sample buffer containing 65 mM Tris-HCl, pH 7.0, 
2% SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.001% bromphenol blue 
and electrophoresed on 6 or 8% SDS-polyacrylamide gels (37). The dried 
gels containing radiolabeled proteins were detected by autoradiography using 
a Kodak XAR-5 x-ray film at –70 °C. The nuclear and cytoplasmic fractions 
from vTF7-3- and vvNS5- or vvNS3-coinfected HeLa cells or from DEN-2-
infected CV-1 cells were isolated as described previously (38). For examin-
ing the interaction between NS3 and NS5 in vitro, the extracts prepared from 
vTF7-3 and vvNS5.H6-coinfected HeLa cells were incubated with nickel-ni-
trilotriacetic acid (Ni NTA) beads (Qiagen) in 0.25 M Tris-Cl, pH 8.0, and 1 
mM phenylmethylsulfonyl fluoride for 10 h at 4 °C with gentle rocking. The 
beads were then washed twice with PBS, pH 7.4, containing 0.3 M NaCl, fol-
lowed by two more washings with PBS, pH 6.8, containing 0.3 M NaCl, to 
remove unbound NS5 and nonspecific proteins. NS5-bound beads were then 
incubated for 2 h at 4 °C with extracts prepared from either vTF7-3-infected, 
or vTF7-3- and vvNS3-coinfected HeLa cells. The beads were washed as de-
scribed above, and the proteins that were bound to NS5-Ni NTA beads were 
analyzed by SDS-PAGE and immunoblotting methods. The immunoblot was 
probed firstly with anti-NS3 antibody and then with goat anti-rabbit coupled 
to alkaline phosphatase.
Phosphoamino Acid Analysis and Two-dimensional Peptide Mapping 
— 32P-Labeled proteins were resolved on 6% SDS-polyacrylamide gels and 
transferred onto nitrocellulose membrane (Bio-Rad). A small portion of the 
membrane was subjected to immunoblot analysis to identify the band of in-
terest. The remaining untreated membrane was subjected to autoradiography, 
and the proteins were eluted from the membrane by digestion with tosylphe-
nylalanyl chloromethyl ketone-treated trypsin as described (39). Phospho-
amino acid analysis was carried out as described (40, 41). Migration of the 
unlabeled standards was determined by ninhydrin staining, and labeled phos-
phoamino acids were visualized by autoradiography. Phosphopeptide analysis 
by two-dimensional finger printing was performed as described (40, 41).
In Vitro Dephosphorylation of NS5 — [35S]Methionine-labeled cytoplas-
mic and nuclear extracts obtained from DEN-2-infected cells were immuno-
precipitated with anti-NS5 antibody and protein A-agarose beads. The beads 
were washed once with the immunoprecipitation wash buffer and twice with 
dephosphorylation buffer (0.15 M sodium acetate buffer, pH 5.0). The beads 
were resuspended in the dephosphorylation buffer, treated with 0.5 unit of po-
tato acid phosphatase for 1 h at 37 °C, and analyzed by SDS-PAGE, followed 
by autoradiography.
Results
Evidence That NS3 and NS5 Interact in Vivo and in Vitro — NS3 
and NS5 proteins are thought to be the components of the putative vi-
ral replicase complex. To examine whether there is a physical interac-
tion between NS3 and NS5, DEN-2-infected cells were metabolically 
labeled with [35S]methionine and analyzed by immunoprecipitation 
using a rabbit polyclonal antibody against NS3, NS5, or rabbit pre-
immune serum. Immunoprecipitates were then subjected to SDS-
PAGE and blotted on to a nitrocellulose membrane. Autoradiography 
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of the blot shows that neither NS5 nor NS3 was immunoprecipitated 
with preimmune serum (Figure 1A, lanes 1 and 6), but NS3 was co-
immunoprecipitated with NS5 when anti-NS5 (Figure 1A, lanes 3 
and 5) or anti-NS3 antibody was used for immunoprecipitation (Fig-
ure 1A, lanes 2 and 4), suggesting a physical interaction between 
these two proteins. To further verify these results and to eliminate 
the possibility that the antisera against one protein may be cross-re-
acting with the other protein, the same blot used for autoradiography 
was analyzed by immunoblotting (Figure 1B). NS5 could be visu-
alized in both anti-NS3 and anti-NS5 immunoprecipitates when the 
blot was probed with anti-NS5 antibody (Figure 1B, lanes 2 and 3). 
In the same way, NS3 could be detected in the anti-NS5 and NS3 im-
munoprecipitates when the blot was probed with anti-NS3 antibody 
(Figure 1B, lanes 4 and 5). However, neither protein could be visu-
alized when preimmune serum was used for immunoprecipitations 
(Figure 1B, lanes 1 and 6).
The results of the experiments described above could not address 
the possibility that other DEN-2 proteins might be involved in fa-
cilitating the interaction between NS3 and NS5. In order to explore 
this possibility, HeLa cells were coinfected with recombinant vac-
cinia viruses encoding NS3 and NS5, and the lysates from these in-
fected cells were used for immunoprecipitations and immunoblotting 
experiments. As the results indicate, NS5 could be coimmunoprecip-
itated with NS3 when either anti-NS3 or anti-NS5 antibody was used 
for immunoprecipitation (Figure 1C, lanes 1 and 4, respectively). 
As a negative control, when vTF7-3 (encoding only T7 RNA poly-
merase)-infected extracts were used for immunoprecipitation with 
NS3 or NS5 antibody, no specific bands were seen (Figure 1C, lanes 
3 and 6). These experiments clearly demonstrated that NS3 and NS5 
proteins interact in vivo in DEN-2-infected CV-1 cells or in HeLa 
cells infected with recombinant vaccinia viruses encoding NS3 and 
NS5 proteins. The results of the latter experiments (Figure 1C) show 
that no other viral protein is required for this interaction. In order 
to examine whether NS3 and NS5 proteins interact in vitro, we con-
structed the recombinant vaccinia virus encoding the NS5 with the 
C-terminal modification (vvNS5.H6) containing the FLAG epitope 
(32) and the histidine tag (33). The modified NS5 (NS5.H6) protein 
expressed in HeLa cells coinfected with vTF7-3 and vvNS5.H6 was 
immobilized to Ni NTA affinity beads, which were then washed as 
described under “Experimental Procedures” to remove any unbound 
NS5.H6 as well as nonspecific proteins. The NS5 attached to the 
beads was incubated with either the extract prepared from the vTF7-
3-infected HeLa cells as negative control or the NS3-containing ex-
tracts prepared from HeLa cells coinfected with vTF7-3 and vvNS3. 
The beads were washed to remove any unbound NS3 as well as non-
specific proteins, and the bound proteins were analyzed by SDS-
PAGE and immunoblotting using anti-NS3 antibodies as described 
under “Experimental Procedures.” As shown in Figure1 D, NS3 was 
retained in the NS5-bound Ni NTA beads (lane 4), whereas little or 
no NS3 was bound to Ni NTA beads in the absence of immobilized 
NS5 protein (lane 1) or when the NS5-bound beads were incubated 
with the vTF7-3 extract (lane 3). The NS3 extract was loaded into 
lane 2 as positive control. These experiments indicate that the NS3 
and NS5 proteins interact in vitro.
Figure 1: NS3 and NS5 interact in vivo. [35S]Methionine-labeled DEN-2-
infected cells were lysed and subjected to immunoprecipitation followed by 
Western blot analysis (B) and autoradiography (A) of the same blot. Lanes 
1 & 6, immunoprecipitation using preimmune serum; lanes 2 & 4, immuno-
precipitation using NS3 antibody (Ab); lanes 3 & 5, immunoprecipitation us-
ing NS5 antibody. For Western blot analysis, lanes 1, 2, & 3 were probed with 
anti-NS5 antibody, and lanes 4, 5, & 6 were probed with anti-NS3 antibody. 
C) HeLa cells coinfected with recombinant vaccinia viruses encoding the T7 
RNA polymerase gene (vTF7-3) and NS5 (vvNS5) were lysed, and the cell 
lysates were immunoprecipitated with anti-NS5 antibody (lanes 2 and 4) and 
anti-NS3 antibody (lanes 1 & 5). In lanes 3 & 6, the vTF7-3-infected cell ly-
sates were immunoprecipitated with anti-NS5 and anti-NS3 antibody, respec-
tively. Immunoprecipitates were subjected to SDS-PAGE and Western blot 
analysis. Lanes 1–3 were probed with anti-NS5 antibody, and lanes 4–6 were 
probed with anti-NS3 antibody. D) The in vitro interaction between NS5.H6 
and NS3 is shown. Extracts prepared from HeLa cells coinfected with vTF7-
3 and vvNS5.H6 were incubated with Ni NTA beads (Qiagen), and the beads 
were washed as described under “Experimental Procedures.” The immobi-
lized NS5 containing beads were incubated with an extract prepared from 
HeLa cells either infected with the vTF7-3 alone (lane 3) or coinfected with 
vTF7-3 and vvNS3 (lane 4). Lane 2 was loaded with the extract from vvNS3-
infected HeLa cells without any treatment, and lane 1 was loaded with the 
sample prepared from the binding of NS3 extract to Ni NTA beads in the ab-
sence of NS5.H6. Binding to Ni NTA beads, washing conditions, SDS-PAGE, 
and immunoblotting analyses were carried out as described under “Experi-
mental Procedures.”
NS3 aNd NS5 ProteiNS of deNgue ViruS tyPe 2  19103
Subcellular Localization of NS3 and NS5 — The results of the 
coimmunoprecipitation experiments showed an association between 
NS3 and NS5 in vivo in both DEN-2-infected CV-1 cells as well as 
in HeLa cells coinfected with recombinant vaccinia viruses encod-
ing NS3 and NS5. The subcellular localization of these proteins in 
DEN-2-infected CV-1 cells as determined by indirect immunofluo-
rescence showed that NS3 was predominantly localized in the cy-
toplasmic and perinuclear regions of the infected cells (Figure 2C), 
whereas the NS5 was distributed predominantly in the nucleus, al-
though some diffuse cytoplasmic staining was also detected (Figure 
2E). Uninfected cells showed no reactivity to the NS3 and NS5 anti-
bodies (Figure 2, A and B). Similar localization patterns of these pro-
teins were observed in CV-1 cells infected with recombinant vaccinia 
NS3 and NS5 viruses (data not shown).
Different Forms of NS5 Exist in Nuclear and Cytoplasmic Frac-
tions — The results obtained from the immunofluorescence and co-
immunoprecipitation experiments support a working hypothesis that 
NS3 and NS5 interact to form a complex in the cytoplasm or in the 
perinuclear region where NS3 is predominantly localized and a dif-
ferent form of NS5 is localized in the nucleus, which is free of NS3. 
In order to investigate this hypothesis, DEN-2-infected cells meta-
bolically labeled with [35S]methionine were fractionated into cyto-
plasmic and nuclear fractions, and the fractions were used for im-
munoprecipitation analyses using anti-NS5 and anti-NS3 antibody or 
preimmune serum (normal rabbit serum) as a negative control (Fig-
ure 3). When cytoplasmic extracts were immunoprecipitated with 
anti-NS5 antibody, two closely migrating bands for NS5 were de-
tected (Figure 3, lane 1), whereas the nuclear extracts predominantly 
contained the slower migrating form of the protein (Figure 3, lane 
2). Furthermore, NS3 could be coimmunoprecipitated with NS5 
only from the cytoplasmic extracts (69-kDa band in Figure 3, lane 
1). When NS3 antibody was used for immunoprecipitation, the faster 
migrating form of NS5 could be predominantly coimmunoprecip-
itated (Figure 3, lane 3). No NS3 was observed in the nuclear ex-
tracts, consistent with its subcellular localization observed by immu-
nofluorescence (Figure 2B). Lanes 5 and 6 of Figure 3 show negative 
controls where preimmune serum was used for immunoprecipitation. 
We also made an interesting observation that the two forms of NS5 
were readily detectable only when DEN-2-infected cells were sub-
jected to a medium containing low serum (2.5%), whereas under nor-
mal serum concentration (10%), only one form was obtained (data 
not shown). The ratio of NS5 to NS3 in the immunoprecipitates was 
also increased under low serum concentration compared with that 
obtained under normal medium (compare Figure3, lanes 1 and 3 with 
Figure 1A, lanes 2-5, respectively). Also, two faster migrating pro-
Figure 2: Subcellular localization of NS3 and 
NS5 in DEN-2-infected cells. Cells were in-
fected with DEN-2 (50 plaque forming units/cell) 
at room temperature for 2 h. 36-48 h postinfec-
tion, cells were trypsinized and plated on cover-
slips. Indirect immunofluorescence was performed 
using anti-NS3 antibody (C) or anti-NS5 antibody 
(E) as described under “Experimental Procedures.” 
D and F are the respective phase contrast pictures. 
Mock-infected cells were used as negative controls 
for anti-NS3 and anti-NS5 antibodies (A and B, 
respectively).
Figure 3: NS5 exists in multiple forms. Cytoplasmic (C) and nuclear ex-
tracts (N) from [35S]methionine-labeled DEN-2-infected cells were immuno-
precipitated, and the immunoprecipitates were subjected to SDS-PAGE and 
autoradiography. Lanes 1 and 2, anti-NS5 antibody; lanes 3 and 4, anti-NS3 
antibody; lanes 5 and 6, preimmune serum as negative controls.
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teins coimmunoprecipitated with NS3 and NS5 from cytoplasmic ex-
tracts of DEN-2-infected cells. The identity of these proteins in the 
NS3/NS5 immune complexes is unknown at present.
NS5 Is Post-translationally Modified — The results of the im-
munoprecipitations with anti-NS5 antibody suggested that the two 
forms of NS5 could be due to post-translational modification. In or-
der to investigate whether NS5 was modified by phosphorylation, 
NS5 was immunoprecipitated from cytoplasmic and nuclear extracts 
of 35S-labeled DEN-2-infected cells. The immunoprecipitated pro-
tein was then treated with potato acid phosphatase, and phosphatase-
treated and untreated controls were analyzed by SDS-PAGE. The re-
sults shown in Figure 4 indicate that after treatment with potato acid 
phosphatase both the cytoplasmic and the nuclear forms of NS5 shift 
to faster migrating forms (compare untreated cytoplasmic and nu-
clear extracts loaded on to lanes 3 and 5 of Figure 4 with the treated 
samples on lanes 2 and 4). The fastest migrating bands present in 
the cytoplasmic and nuclear extracts immunoprecipitated by the anti-
NS5 antibody were sensitive to potato acid phosphatase treatment, 
but the identity of these bands is unknown at present. The negative 
control for these immunoprecipitations is shown in Figure 4, lane 1, 
in which the unfractionated cell extract was used for immunoprecipi-
tation with preimmune serum (NRS).
The sensitivity of immunoprecipitated nuclear and cytoplasmic 
forms of NS5 to the phosphatase treatment suggested that the multi-
ple forms of NS5 may be due to differential phosphorylation. In or-
der to verify this possibility more directly, CV-1 cells infected with 
DEN-2 and HeLa cells infected with recombinant vaccinia virus en-
coding NS5 were metabolically labeled using [32P]orthophosphate. 
Labeled extracts were immunoprecipitated and analyzed by SDS-
PAGE followed by autoradiography (Figure 5). As shown in Figure 5, 
32P-labeled NS5 could be immunoprecipitated with anti-NS5 anti-
body from both the recombinant vaccinia NS5 virus-infected HeLa 
cell extracts (lane 2) and the DEN-2-infected CV-1 cell extracts (lane 
3). As a positive control, NS5 was immunoprecipitated using anti-
NS5 antibody from 35S-labeled DEN-2-infected cell extract (Figure 
5, lane 1), and as negative controls, extracts of HeLa cells infected 
with only the T7 RNA polymerase gene-encoded recombinant vac-
cinia virus vTF7-3 were immunoprecipitated with anti-NS5 antibody 
(lane 6) or the extracts used in lanes 2 and 3 with normal rabbit se-
rum (lanes 5 and 4, respectively). These results confirm that NS5 is 
a phosphoprotein. The identity of the phosphorylated form of NS5 
was also verified by immunoblot analysis of the anti-NS5 immuno-
precipitate prepared from 32P-labeled DEN-2-infected cell extracts, 
followed by autoradiography of the blot (data not shown).
Phosphoamino Acid Analysis and Phosphopeptide Mapping — In 
order to analyze the amino acid residues that were modified by phos-
phorylation, phosphoamino acid analyses of the 32P-labeled NS5 
produced in DEN-2-infected CV-1 cells and in recombinant vaccinia 
NS5 virus-infected HeLa cells were carried out. The results shown in 
Figure 6A for recombinant NS5 indicate that phosphate groups are 
associated only with serine residues (Figure 6A), similar to the pat-
tern observed for native NS5 (data not shown). In order to determine 
whether a single or multiple serines were modified in NS5, two-di-
mensional phosphopeptide mapping was performed using 32P-la-
beled NS5 obtained from recombinant vaccinia NS5 virus-infected 
HeLa cells (Figure 6B). The results show that there are at least four 
distinct phosphorylation sites in addition to a few minor ones.
Discussion
The experimental evidence presented in this report indicates that 
the two non-structural proteins, NS3 and NS5, interact in vivo both 
in DEN-2-infected CV-1 cells and HeLa cells infected with recombi-
nant vaccinia viruses encoding these proteins. Using the NS5.H6 im-
Figure 4: Multiple forms of NS5 are due to differential phosphoryla-
tion. Cytoplasmic (C) and nuclear (N) extracts from [35S]methionine-labeled 
DEN-2-infected cells were used for immunoprecipitation with anti-NS5 anti-
body (Ab). Immunoprecipitated NS5 was either treated with potato acid phos-
phatase (lanes 2 and 4) or left untreated (lanes 3 and 5). Lane 1 is a negative 
control where DEN-2-infected whole cell extract was used for immunopre-
cipitation with preimmune serum. Immunoprecipitates were analyzed by 
SDS-PAGE and autoradiography.
Figure 5: Evidence for Phosphorylation of NS5. CV-1 cells infected with 
DEN-2 or HeLa cells infected with vvNS5 were metabolically labeled with 
[32P]orthophosphate. Cell lysates were immunoprecipitated and analyzed by 
SDS-PAGE and autoradiography. [35S]Methionine-labeled DEN-2-infected 
CV-1 cell lysate (positive control) with anti-NS5 antibody (lane 1); vTF7-3- 
and vvNS5-coinfected cell lysate with anti-NS5 antibody (lane 2) or with pre-
immune serum (lane 5); DEN-2-infected cell lysate with anti-NS5 antibody 
(lane 3) or with preimmune serum (lane 4); vTF7-3 infected cell lysate with 
anti-NS5 antibody (lane 6).
Figure 6: Phosphoamino acid analysis and phophopeptide mapping. A) 
32P-labeled NS5 from recombinant vaccinia NS5-infected cells was acid hydro-
lyzed and mixed with unlabeled phosphoserine, phosphothreonine, and phos-
photyrosine as standards. The mixture was subjected to two-dimensional elec-
trophoresis on thin-layer cellulose-coated plates using buffers at pH 1.9 and 3.5 
for the first and second dimensions, respectively. Labeled phosphoamino ac-
ids were detected by autoradiography, and the migration of unlabeled phospho-
amino acids was determined by ninhydrin staining (shown as dotted circles). 
PS, phosphoserine; PT, phosphothreonine; PY, phosphotyrosine. Partially hy-
drolyzed NS5 is seen as a smear below the phosphoamino acids. B) 32P-labeled 
NS5 was digested with tosylphenylalanyl chloromethyl ketone-treated trypsin. 
Tryptic digests were subjected to electrophoresis in the first dimension and as-
cending chromatography in the second dimension on thin-layer cellulose plates. 
Phosphopeptides were detected by autoradiography.
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mobilized to an affinity matrix (Ni NTA beads), we show that these 
two proteins also interact in vitro. This interaction between NS3 and 
NS5 supports the notion that they are components of the putative vi-
ral replicase postulated in earlier studies (6, 42) based on the pres-
ence of conserved motifs of a RNA helicase in NS3 and the G-D-
D motif in NS5 characteristic of RNA-dependent RNA polymerases 
(12, 26, 28). The data obtained from the in vivo and in vitro inter-
action studies using the recombinant vaccinia virus-infected cell ex-
tracts indicate that no other flavivirus protein is required for this in-
teraction. However, a requirement of a cellular protein(s) for this 
interaction or participation of other viral and cellular proteins in sta-
bilization of this complex cannot be ruled out.
Flavivirus genome replication is thought to occur through the for-
mation of double-stranded RNA replicative intermediate (23, 24, 25, 
42). Subcellular localization studies revealed that virus-specific dou-
ble-stranded RNA appeared to be associated in the perinuclear region 
of the infected cells (5, 43, 45). The cell fractionation studies also 
supported these results and further indicated that viral RNA synthe-
sis appeared to be confined principally to the membranes of the peri-
nuclear endoplasmic reticulum (5, 46, 47, 48, 49, 50). Both NS3 and 
NS5 proteins of flavivirus are predicted to have enzymatic roles in 
flavivirus RNA replication. Although both proteins have been found 
to be present in the subcellular fractions containing the RNA poly-
merase activity, direct interaction between these two proteins has not 
been demonstrated previously.
Previous studies have reported that NS5 of two other flaviviruses 
is localized in the nucleus and cytoplasm of infected cells (51, 52). 
This study, as shown by immunofluorescence, subcellular fraction-
ation, and immunoprecipitation methods, shows that there are two 
forms of NS5 present in the cytoplasmic fraction that are separable 
by SDS-PAGE. Only the form with the slower mobility is predom-
inantly located in the nuclear fraction. The multiple forms of NS5 
are due to differential phosphorylation, and the hyperphosphorylated 
form is located predominantly in the nucleus. The presence of two 
forms of NS5 in DEN-2-infected cells was serentipitously discovered 
by incubating the infected cells with a medium containing low serum 
(2.5%). The slower migrating form seems to be the hyperphosphory-
lated form when compared with the faster migrating and hypophos-
phorylated cytoplasmic form. Under normal growth conditions con-
taining 10% serum, only one form of NS5 was observed. The result 
that only the cytoplasmic form of NS5 was found to form a com-
plex with NS3 suggests that differential phosphorylation may regu-
late the interaction between NS3 and NS5 and thus their participation 
as components in viral RNA replication. 
Based on these results we propose a model as shown in Figure 
7. According to this model, the RNA replicase complex containing 
NS3 and NS5 participate in viral RNA replication associated with the 
endoplasmic reticulum membrane. In a postreplicative event, NS5 
becomes hyperphosphorylated, dissociates from NS3, and is trans-
ported to the nucleus. It is known that post-translational modifica-
tion by phosphorylation regulates protein-protein interactions in eu-
karyotic cells (for reviews, see references 51 and 52). For instance, 
in the case of the retinoblastoma gene product (Rb), its state of phos-
phorylation is important for its interaction with the cellular transcrip-
tion factor E2F (for a review, see reference 53 and the references 
therein). The phosphorylation state of Rb varies in different stages of 
the cell cycle. The protein is in a hypophosphorylated stage at the G0/
G1 phase, during which it is in a complex with E2F. During the G1/S 
phase, Rb gets hyperphosphorylated and dissociates from E2F. Simi-
larly, phosphorylation of IκB results in the dissociation of NFκB-IκB 
complex and translocation of NFκB to the nucleus (54, 55).
The poliovirus RNA-dependent RNA polymerase, 3Dpol is a phos-
phoprotein (56), but the role of phosphorylation in the function of 
3Dpol is unknown. For NS5, phosphorylation may play a role in its 
nuclear transport, because only the slower migrating hyperphosphor-
ylated form is present in the nucleus. In this regard, it is worth not-
ing that phosphorylation has been shown to play a role in the nu-
clear transport of SV40 large T antigen (57, 58). The role of NS5 in 
the nucleus is unknown at present. An interesting speculation is that 
NS5 may regulate the expression of cellular genes in response to vi-
ral infection. 
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